Compare FG & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FG | NOVT |
|---|---|---|
| Founded | 1959 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 5.0B |
| IPO Year | 2023 | 1999 |
| Metric | FG | NOVT |
|---|---|---|
| Price | $25.04 | $148.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $31.00 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 525.8K | 282.0K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.24 | 0.82 |
| Revenue | ★ $5,731,000,000.00 | $521,290,000.00 |
| Revenue This Year | $7.94 | $8.61 |
| Revenue Next Year | $5.51 | $6.57 |
| P/E Ratio | ★ $20.19 | $180.93 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $20.57 | $98.27 |
| 52 Week High | $35.33 | $176.38 |
| Indicator | FG | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 43.61 | 47.04 |
| Support Level | $23.79 | $146.45 |
| Resistance Level | $29.77 | $149.42 |
| Average True Range (ATR) | 0.92 | 6.14 |
| MACD | 0.13 | -0.65 |
| Stochastic Oscillator | 47.36 | 27.39 |
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.